Year: 2020

news_6

Final Results from the Phase 3 HELP Study™ Open-Label Extension Support TAKHZYRO® (lanadelumab-flyo) Injection as a Long-term Preventive Treatment Option in Patients with Hereditary Angioedema

news_6

The Access Group Acquires Unleashed Software to Expand Its Global Presence and Potential in Manufacturing, Wholesale and Distribution Markets

LOUGHBOROUGH, England & AUCKLAND, New Zealand--(BUSINESS WIRE)--#distribution--The Access Group today announced the acquisition of Unleashed, a New Zealand headquartered organisation...